Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI
2011

Long-term CD4+ T-cell Count Changes After Switching HIV Treatments

Sample size: 896 publication 10 minutes Evidence: high

Author Information

Author(s): Torti Carlo, d'Arminio-Monforte Antonella, Pozniak Anton L, Lapadula Giuseppe, Cologni Giuliana, Antinori Andrea, De Luca Andrea, Mussini Cristina, Castagna Antonella, Cicconi Paola, Minoli Lorenzo, Costantini Andrea, Carosi Giampiero, Liang Hua, Cesana Bruno M

Primary Institution: University of Brescia, Italy

Hypothesis

Does switching from protease inhibitor-based regimens to non-protease inhibitor regimens affect CD4+ T-cell recovery in HIV patients?

Conclusion

Switching from first-line protease inhibitor regimens to NNRTI or NRTI-based regimens did not impair the long-term CD4+ T-cell trend.

Supporting Evidence

  • Patients switched to NRTI-only regimens showed greater CD4+ count increases due to higher baseline counts.
  • Only 6.9% of patients showed a decrease in CD4+ counts within 180 days of switching.
  • Statistical analyses indicated no significant differences in CD4+ trends after switching treatments.

Takeaway

This study looked at how changing HIV treatments affects a type of immune cell called CD4+ T-cells. It found that switching treatments didn't hurt the recovery of these cells over time.

Methodology

Retrospective inter-cohort study analyzing CD4+ T-cell counts in patients who switched from PI-based regimens to NNRTI or NRTI-only regimens.

Potential Biases

Potential selection bias favoring the NRTI group due to exclusion of patients who continued on PI.

Limitations

The study was not randomized, which may introduce selection bias, and it relied on a 500 copies/ml cut-off for undetectable HIV RNA.

Participant Demographics

896 patients, median age 39 years, predominantly male (79.9%), with various risk factors for HIV acquisition.

Statistical Information

P-Value

P = 0.0024

Confidence Interval

95%CI = 0.81-0.89

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2334-11-23

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication